⚠ FDA NOTICE: These products are NOT FDA approved for human use. Sold for research purposes only. Not for human consumption.
🎟 Have a code? Apply for member pricing:

Research Compound Catalog

Browse our planned peptide formulations. None are currently available for purchase.

⚠ Reminder: These products are NOT FDA approved and cannot be purchased at this time. Prices shown are projected retail prices for when approval is obtained.

Retatrutide

$120.00

Vial Size: 10 mg

Triple receptor agonist (GLP-1 / GIP / Glucagon). Most powerful weight-loss compound in trials (~24%).

SKU: PP-RET-10 Category:

Description

Retatrutide – 10 mg

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. The glucagon component adds metabolic rate increases on top of appetite suppression.

Common Applications:

  • Substantial weight loss (24%+ in trials)
  • Metabolic syndrome
  • Type 2 diabetes
  • Cases where tirzepatide plateaued

Reference Dosing:

Conservative titration: 2 mg/wk x 4 weeks → 4 mg x 4 → 6, 8, up to 12 mg max.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide”

Your email address will not be published. Required fields are marked *

Important Notice

These products are NOT currently FDA approved.

The peptide compounds described on this site are for informational and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease.

The information provided is based on current scientific research and literature regarding peptide compounds. These products are presented as a preview of what may become available pending FDA regulatory approval.

Always consult with a qualified healthcare professional before starting any new supplement or wellness program.